Anti-CD298/ATP1B3 antibody (180-279 aa) [SRM] (STJ11106584)

SKU:
STJ11106584

Current Stock:
Host: Rabbit
Applications: WB/IHC-P/IF/ICC/ELISA
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality: Monoclonal
Clone ID: SRM
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.09% Sodium Azide, 0.05% BSA, 50% Glycerol, pH 7.3.
Purification: Affinity purification
Concentration: Lot specific
Dilution Range: WB:1:1500-1:3000
IHC-P:1:100-1:500
IF/ICC:1:200-1:800
ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements.
Gene Symbol: ATP1B3
Gene ID: 483
Uniprot ID: AT1B3_HUMAN
Immunogen Region: 180-279 aa
Specificity: A synthetic peptide corresponding to a sequence within amino acids 180-279 of human ATP1B3 (P54709).
Immunogen Sequence: GLKPEGVPRIDCVSKNEDIP NVAVYPHNGMIDLKYFPYYG KKLHVGYLQPLVAVQVSFAP NNTGKEVTVECKIDGSANLK SQDDRDKFLGRVMFKITARA
Function This is the non-catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of Na(+) and K(+) ions across the plasma membrane. The exact function of the beta-3 subunit is not known.
Protein Name Sodium/Potassium-Transporting Atpase Subunit Beta-3
Sodium/Potassium-Dependent Atpase Subunit Beta-3
Atpb-3
Cd Antigen Cd298
Database Links Reactome: R-HSA-210991
Reactome: R-HSA-5578775
Reactome: R-HSA-936837
Reactome: R-HSA-9679191
Cellular Localisation Apical Cell Membrane
Single-Pass Type Ii Membrane Protein
Basolateral Cell Membrane
Melanosome
Identified By Mass Spectrometry In Melanosome Fractions From Stage I To Stage Iv
Alternative Antibody Names Anti-Sodium/Potassium-Transporting Atpase Subunit Beta-3 antibody
Anti-Sodium/Potassium-Dependent Atpase Subunit Beta-3 antibody
Anti-Atpb-3 antibody
Anti-Cd Antigen Cd298 antibody
Anti-ATP1B3 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance